Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Enzymatics' Archer Analysis; DNAStar's Lasergene

Premium

Enzymatics has launched version 3 of its Archer Analysis Pipeline. It's the latest incarnation of the company's next-generation sequence analysis platform for detecting and characterizing cancer-causing gene fusions and mutations from clinical samples. The solution lets users call known or novel genomic alterations. It includes robust quality control systems, clear, detailed analytics, and interactive visualizations using JBrowse, among other features.


DNAStar has launched Lasergene 12.1, which integrates cloud capability with desktop software to allow scientists to run multiple sequence assemblies on the cloud simultaneously. The solution also includes DNAStar Data Drive, which enables fast, secure data transfer between desktop computers and the cloud. It also includes protein function and binding site prediction tools and more.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.